ada glp 1 recommendations The 2026 Standards of Care mark a continued evolution in diabetes pharmacotherapy, more formally incorporating GLP-1 receptor agonists into organ-specific treatment algorithms. Key updates to Section 9 recommendations: Cardiovascular Consensus Recommendations on GLP-1 RA
Description
Healthcare Happenings I do these chats every week

Diabetes 2012;61:275362

The data are provided by patients and collected by the UK National Health Service as part of their care and support

We need to be able to say, Im going to treat your diabetes, but

they may be quietly reshaping the timing of reward